BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA
Clinical trials for BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a common blood pressure pill boost radiation against tough pancreatic tumors?
Disease control OngoingThis early-phase study tests whether adding the blood pressure drug losartan to a shorter, stronger course of radiation can help treat pancreatic cancer that is either hard to remove surgically or has spread locally. Losartan may improve blood flow and oxygen in the tumor, making…
Matched conditions: BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: University of Utah • Aim: Disease control
Last updated May 26, 2026 07:59 UTC
-
Promising combo targets pancreatic tumors before surgery
Disease control OngoingThis study tests whether giving a mix of chemotherapy (gemcitabine, nab-paclitaxel) and immunotherapy (durvalumab, oleclumab) before surgery can shrink pancreatic tumors and improve outcomes. It involves 13 adults with early-stage, removable pancreatic cancer. The goal is to see …
Matched conditions: BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
New combo therapy aims to control hard-to-treat pancreatic cancer
Disease control TerminatedThis early-phase study tests a drug called NBTXR3, which is activated by radiation, in people with pancreatic cancer that is locally advanced or borderline resectable. The goal is to find a safe dose and see if it helps control the disease. About 24 adults will take part, and the…
Matched conditions: BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
Promising pancreatic cancer study pulled before it began
Knowledge-focused TerminatedThis study aimed to test new therapies for people with pancreatic cancer that hasn't spread. It was designed to compare experimental treatments against standard chemotherapy in three groups based on how far the cancer had grown. However, the study was withdrawn before enrolling a…
Matched conditions: BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 13:55 UTC